Home›People›Carrie Powers
Carrie Powers

Carrie Powers

President and Chief Executive Officer, director at Reprise Biomedical.

ExecutiveDirectorPublic company
Updated Nov 10, 2026·Latest SEC filing Jul 1, 2026·Suggest an edit

About Carrie Powers

Carrie Powers is a president and chief executive officer, director at Reprise Biomedical.

Carrie Powers reports to the SEC as an officer of 1 public company: Vascular Solutions (VASC).

Carrie Powers first appears on SEC filings in 2009.

Experience

This experience comes from Carrie Powers's profile and from SEC filings. For roles taken from filings, the years are when the filings name Carrie Powers in the role, so the role may have started earlier or lasted longer.

Reprise Biomedical, Inc. Current
President and Chief Executive Officer, director
2019 – Present · Plymouth, MN
Makes biological wound care devices for physicians treating patients.
CHF Solutions, Inc.
Sr. Vice President of Commercial Operations
2018 – 2019
Teleflex Incorporated
Senior Director Clinical and Medical Affairs
2017 – 2018
Vascular Solutions Inc.
Sr. VP of Marketing
Sr. Vice President of Marketing (2006 – 2017)
2006 – 2017 · Public company (VASC)
St. Mary's Hospital - SSM Health
RN - Diagnostic & Interventional Cardiology
2001 – 2006
UPC Health Network
Patient Services - Respiratory Care & Infusion Therapy
1998 – 2001

Key Colleagues at Startups

The people Carrie Powers works with at each company, as listed on that company's latest Form D.

Reprise Biomedical, Inc. · Form D/A, Jul 1, 2026
Jake Isenburg
Jake Isenburg
Vice President of Research and Development
PN
Phil Nalbone
Director
Heather Kotila
Heather Kotila
Vice President of Human Resources
Jerrod Krueger
Jerrod Krueger
Vice President of Manufacturing
Tom Kouchoukos
Tom Kouchoukos
Vice President of Marketing
HR
Howard Root
Director
Greg Smock
Greg Smock
General Counsel and Chief Compliance Officer
SJ
Steve Jagodzinski
Controller and Treasurer
AW
Alan Woldt
Director
Jeff Duncan
Jeff Duncan
Vice President of Quality
EK
Erwin Kelen
Director

Sources

  1. SECReprise Biomedical, Inc. Form D/A, filed Jul 1, 2026
  2. SECForms 3, 4 and 5 filed by Carrie Powers (SEC filer 1465115)